One stop for all your health tips
Blueprint Medicines Corporation today announced the European Commission has approved AYVAKYT® (avapritinib) for the treatment of adult patients with indolent systemic mastocytosis (ISM) with moderate to severe symptoms inadequately controlled on symptomatic treatment. AYVAKYT is the first and only approved therapy for people living with ISM in Europe. Systemic mastocytosis (SM) is a rare hematologic disorder that can […]
Choosing Between Levi’s 501, 505, 511, and 514? Start Here
Winter Western: The Sendero Cloudcroft Hooded Puffer Jacket
Three Day Rule: Why Matchmaking is the Future for Finding Real Lasting Love
Your Comparison Chart for Levi’s Most Popular Fits
All the best new winter menswear arrivals from ROARK
Willy Chavarria x adidas Originals Is Redefining Sportswear
